Summary
- Current Price
- MRNS price is unknown, with unknown change on
- Current Price All-Time High
- MRNS price vs all-time high is unknown
- Market Cap
- MRNS market cap is unknown, with unknown 1-year change
- PE Ratio
- MRNS PE ratio is unknown
- Revenue
- MRNS current annual revenue is $30.99M, up +21.63% year-over-year
- Next Earnings
- As of today, the next earnings release for MRNS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Marinus Pharmaceuticals, Inc. |
| Ticker | NASDAQ: MRNS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | marinuspharma.com |
| Employees | 165 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| - | ||
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $31M | ||
| Revenue, 1Y Change | +21.63% | |
| -$2.63 | ||
| EPS, 1Y Change | -415.69% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.63 | ||
| EPS Estimate | N/A | -$2.08 |
| EPS Est. Change | N/A | +20.79% |
| $30.99M | ||
| Revenue Estimate | N/A | $34.87M |
| Revenue Est. Change | N/A | +12.52% |
| - | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.52 | -$2.63 | -4.37% | |
| -$2.08 | N/A | +20.79% | |
| -$0.58 | N/A | +78.14% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $31.81M | $30.99M | -2.58% | |
| $34.87M | N/A | +12.52% | |
| $53.92M | N/A | +74.01% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +21.63% | ||
| +1,703.78% | ||
| -415.69% | ||
| +6.07% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| - | ||
| N/A | - | |
| SMA 200 vs Price | N/A | - |
| N/A | - | |
| SMA 50 vs Price | N/A | - |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $30.99M | ||
| -$2.63 | ||
| $29.06M | ||
| 93.76% | ||
| -$131.49M | ||
| -424.30% | ||
| -$141.41M | ||
| -456.31% | ||
| -$125.50M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 4.35 | ||
| 4.07 | ||
| 4.01 | ||
| -7.46 | ||
| 3 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $16.77M | ||
| $120.57M | ||
| $170.91M | ||
| $165.25M | ||
| $154.14M | ||
| $40.62M | ||
| $73.75M | ||
| $12.33M | ||
| $4.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $162.47M | ||
| $160.54M | ||
| $1.93M | ||
| $61.15M | ||
| $551.00K | ||
| $16.90M | ||
| -$1.54M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$118.00M | ||
| -$28.61M | ||
| $26.63M | ||
| $119.00K | ||
| -$118.12M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| TD Cowen | → | |
| RBC Capital | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| JMP Securities | → | |
| EF Hutton | → | |
| Ladenburg Thalmann | → |
Analyst sentiment
Institutional ownership
Screeners with MRNS
FAQ
What is the ticker symbol for Marinus Pharmaceuticals, Inc.?
The ticker symbol for Marinus Pharmaceuticals, Inc. is NASDAQ:MRNS
Does Marinus Pharmaceuticals, Inc. pay dividends?
No, Marinus Pharmaceuticals, Inc. does not pay dividends
What sector is Marinus Pharmaceuticals, Inc. in?
Marinus Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Marinus Pharmaceuticals, Inc. in?
Marinus Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Marinus Pharmaceuticals, Inc. based in?
Marinus Pharmaceuticals, Inc. is headquartered in United States
When did Marinus Pharmaceuticals, Inc. go public?
Marinus Pharmaceuticals, Inc. initial public offering (IPO) was on July 31, 2014
Is Marinus Pharmaceuticals, Inc. in the S&P 500?
No, Marinus Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Marinus Pharmaceuticals, Inc. in the NASDAQ 100?
No, Marinus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Marinus Pharmaceuticals, Inc. in the Dow Jones?
No, Marinus Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Marinus Pharmaceuticals, Inc. last earnings report?
Marinus Pharmaceuticals, Inc.'s most recent earnings report was on March 5, 2025
When does Marinus Pharmaceuticals, Inc. report earnings?
The date for Marinus Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MRNS Official Website marinuspharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1267813/000155837024015315/0001558370-24-015315-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1267813/000155837024002479/0001558370-24-002479-index.htm
- MRNS Profile on Yahoo Finance finance.yahoo.com/quote/MRNS
- MRNS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrns